Post-earnings recap
Reported
Wed, May 1, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Charles River Laboratories fell slightly short of expectations on EPS, which contributed to a 1.03% decline in stock price. Investors may be cautious due to the lack of revenue data and guidance. However, management's focus on long-term growth could provide reassurance for future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.69 | N/A | -2.82% |
Overall, management remains focused on strategic initiatives despite the slight EPS miss. They emphasized the importance of long-term growth.
Management expressed confidence in the long-term growth strategy.
They highlighted ongoing investments in innovation and capacity expansion.